or
forgot password
  • cancer clinical trials in bethesda, MD

  • Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Cutaneous Leiomyomas, Hereditary Leiomyomatosis and Renal Cell Cancer
    A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Prostatic Neoplasms, Prostate Specific Antigens
    A Multi-Histology Phase II Study of 5-Fluoro-2-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Head and Neck Neoplasms, Lung Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Childhood Hepatoblastoma, Stage I Childhood Liver Cancer, Stage II Childhood Liver Cancer, Stage III Childhood Liver Cancer, Stage IV Childhood Liver Cancer
    Pilot Study of Radiation-Enhanced Allogeneic Cell Therapy for Progressive Hematologic Malignancy After Allogeneic Hematopoietic Stem Cell Transplantation
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemias, Multiple Myeloma With Plasmacytoma
    Maraviroc (CCR5) Antagonism to Decrease the Incidence of the Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients
    NIH/NIAD
    Bethesda, Maryland 20892
    Immune Reconstitution Inflammatory Syndrome, HIV, HIV Infections
    A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Glioblastoma Multiforme, Gliosarcoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Mixed Oligoastrocytoma
    Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
    National Naval Medical Center
    Bethesda, Maryland 20889
    Lymphoma, Lymphoproliferative Disorder
    Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neuroendocrine Neoplasms, Thyroid Neoplasms, Parathyroid Neoplasms, Adrenal Neoplasm, Neuroblastoma
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Suburban Hospital
    Bethesda, Maryland 20814
    Breast Cancer, Cardiac Toxicity
    Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
    NIH, Center for Cancer Research, Medical Oncology
    Bethesda, Maryland 20892
    Thymic Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Metastatic Melanoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    A Phase I Study of Intravenous Recombinant Human IL-15 in Adults With Refractory Metastatic Malignant Melanoma and Metastatic Renal Cell Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Melanoma, Carcinoma, Renal Cell
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Lymphoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Metastatic Breast Cancer
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Non-Small-Cell Lung Cancer
    Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Metastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage IV Adult Soft Tissue Sarcoma
    Phase II Study for the Evaluation of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
    Center for Cancer and Blood Disorders

    Trial Locations
    Center for Cancer and Blood Disorders
    National Capital Clinical Research Consortium
    Multiple Myeloma
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    National Capital Clinical Research Consortium
    Bethesda, Maryland 20817
    Extensive-Stage Small Cell Lung Cancer
    Phenomenological Study of Psycho-Socio-Spiritual Healing in the Context of Chronic or Life-Threatening Illness
    National Institutes of Health Clinical Center, 9000 Rockville Pike

    Trial Locations
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Suburban Hospital - Cardiac Rehabilitation Service
    Cancer, Pain
    A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Breast Cancer, Lung Cancer, Renal Cancer, Adrenal Cancer
    Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkins Lymphoma (NHL), Cutaneous T Cell Lymphoma (CTCL), Adult T Cell Lymphoma (ATL)
    Study to Investigate CAL-101 in Combination With Chemotherapeutic Agents and CD20 mAb in Patients With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia
    Center for Cancer and Blood Disorders
    Bethesda, Maryland 20817
    Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma
    Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Childhood Low-grade Cerebellar Astrocytoma, Childhood Low-grade Cerebral Astrocytoma, Childhood Mixed Glioma, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma
    An Extension Study for Patients Who Are Deriving Benefit With CAL-101 to Continue on Treatment at the End of the Current Study
    Center for Cancer & Blood Disorders, PC
    Bethesda, Maryland 20817
    Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin, Acute Myeloid Leukemia, Multiple Myeloma
    A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC)
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Prostate Cancer, Metastatic Castrate Resistant Prostate Cancer
    Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Burkitt Lymphoma, Diffuse Large B-cell Lymphoma, c-MYC Positive
    A Phase I Trial of Safety and Immunogenicity of Gardasil(Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients With and Without Immunosuppression
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Gardasil Vaccine, Stem Cell Transplant, Immunogenicity, Quadrivalent HPC Vaccine, Healthy Volunteers
    Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Younger Patients With Newly Diagnosed Ependymoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Childhood Infratentorial Ependymoma, Childhood Supratentorial Ependymoma, Newly Diagnosed Childhood Ependymoma
    A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Thymoma, Thymic Carcinoma
    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    Suburban Hospital
    Bethesda, Maryland 20814
    Breast Cancer
    Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Sarcoma, Endocrine Tumors, Neuroblastoma, Retinoblastoma, Renal Cancer
    Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Smoldering Myeloma, Monoclonal Gammopathy of Undetermined Significance
    Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Non-Medullary Thyroid Cancer
    Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pediatric Cancer, Leukemia, Sarcoma, Brain Tumors
    A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Neoplasms, Liver Metastases
    A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    HLRCC, Metastatic Papillary RCC
    Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
    National Naval Medical Center
    Bethesda, Maryland 20889
    Breast Cancer, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Temsirolimus, Irinotecan Hydrochloride, and Temozolomide in Treating Younger Patients With Relapsed or Refractory Solid Tumors
    Mark O Hatfield-Warren Grant Magnuson Clinical Center
    Bethesda, Maryland 20892
    Unspecified Childhood Solid Tumor, Protocol Specific
    Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    National Naval Medical Center
    Bethesda, Maryland 20889
    Leukemia
    A Multicenter, Open-label Study of CMX001 Treatment of Serious Diseases or Conditions Caused by dsDNA Viruses
    NIH
    Bethesda, Maryland 20892
    Male or Female Patients With a Serious or Immediately Life-threatening, Disease or Condition Caused by CMV, ADV, HSV, VAVC, VARV or, Monkeypox Viruses(s) Who Have a Life Expectancy of ≥ 2 Weeks and for, Whom no Comparable or Satisfactory Alternative Therapy is Available
    Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Thymoma, Thymic Carcinoma
    Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site
    National Cancer Institute (NCI), 9000 Rockville Pike
    Bethesda, Maryland 20892
    Helicobacter Pylori
    A Phase II Study of Ofatumumab-Based Induction Chemoimmunotheraphy Followed by Consolidation Ofatumumab Immunotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Small Lymphocytic Lymphoma, CLL (Chronic Lymphocytic Leukemia)
    Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Safety Study of MGAH22 in HER2-positive Carcinomas
    National Cancer Institute
    Bethesda, Maryland 20892-1922
    Breast Cancer, Gastric Cancer, Bladder Cancer, Ovarian Cancer, Non-small Cell Lung Cancer
    Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
    National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892
    Pleural Mesothelioma, Peritoneal Mesothelioma
    A Study of Pemetrexed & Carboplatin/Cisplatin or Gemcitabine & Carboplatin/Cisplatin With or Without IMC-1121B in Patients Previously Untreated With Recurrent or Advanced Non-small Cell Lung Cancer (NSCLC)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Carcinoma, Non-Small-Cell Lung
    INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
    Bethesda, Maryland 20892-1182
    Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unspecified Childhood Solid Tumor, Protocol Specific
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Bethesda, Maryland 20817
    Non Small Cell Lung Cancer
    Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
    Walter Reed National Military Medical Center
    Bethesda, Maryland 20889
    Light Chain Deposition Disease, Smoldering Multiple Myeloma